1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases: highly potent 2,6-Difluorophenacyl analogues.
暂无分享，去创建一个
J. Tokarski | S. D. Kimball | K. Webster | R. Misra | Hai-yun Xiao | J. Mulheron | J. Sack | D. B. Rawlins | Weifang Shan | K. Kellar
[1] John S Tokarski,et al. 1H-Pyrazolo[3,4-b]pyridine inhibitors of cyclin-dependent kinases. , 2003, Bioorganic & medicinal chemistry letters.
[2] Punit Marathe,et al. Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities. , 2002, Journal of medicinal chemistry.
[3] K. Webster,et al. Novel drugs targeting the cell cycle , 2000 .
[4] G L Trainor,et al. Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation. , 2000, Journal of medicinal chemistry.
[5] K. Webster,et al. The therapeutic potential of targeting the cell cycle. , 1998, Expert opinion on investigational drugs.
[6] C. Sherr. Cancer Cell Cycles , 1996, Science.
[7] T. Hunter,et al. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.
[8] J. Pines,et al. The cell cycle kinases. , 1994, Seminars in cancer biology.
[9] S. Nahm,et al. N-methoxy-n-methylamides as effective acylating agents , 1982 .
[10] K. Webster,et al. Chapter 14. Cell cycle kinases and checkpoint regulation in cancer , 2001 .
[11] P. Ponath. Chemokine receptor antagonists: novel therapeutics for inflammation and AIDS. , 1998, Expert opinion on investigational drugs.
[12] H. Höhn,et al. Synthese von 1 H‐Pyrazolo[3,4‐b]pyridin‐5‐ketonen , 1976 .